They described the presence of IgM-class anti-CoV antibodies in 12% (n = 183) of patients with clinical suspicion of acute encephalitis, different from that reported for prior MERS-CoV infection (26% in patients with mental disorders and 9% in those with a history of seizures). Here, CD40LG is linked to mental disorder.